MUC16 and colorectal carcinoma: For CRC cases with stage II or III disease and plasma protein measurement (n = 95), we found both CA-125 and PPP1R1A to associate with survival after adjusting for stage (II vs III), year of diagnosis and age at diagnosis (HR = 2.26, p = 0.0013 for CA-125, HR = 1.99, p = 0.0035 for PPP1R1A).